← Back to front page
Europe · General news · Daily Express

Boots to become first UK pharmacy to prescribe cannabis

Published by Daily Express · United Kingdom 8 h ago
Boots to become first UK pharmacy to prescribe cannabis
Daily Express

Detailed summary

Mon, Nov 16, 2026 A major UK pharmacy is set to become the first in the country to privately prescribe cannabis. Boots will provide the Class B drug to over-25s suffering from…

A major UK pharmacy is set to become the first in the country to privately prescribe cannabis. Boots will provide the Class B drug to over-25s suffering from insomnia, chronic pain or generalised anxiety, a spokesperson confirmed.

Patients will first need to try traditional treatments and undergo screening for histories of psychosis or other disqualifying health conditions. Those eligible could be prescribed cannabis flower or oil for a 28-day period, with the lowest dosage costing just under £40.

The drug will be distributed through Boots Online Doctor's Sureleaf service, also subject to video consultation. Jamie Kerruish, chief healthcare officer at Boots, said: "At Boots, we're committed to making healthcare more accessible and helping people find the right support for thir individual needs."

"Millions of people live with ongoing pain and for some, conventional treatments do not provide adequate symptom relief," he added. "This can have a significant impact on everyday life, from working and sleeping well to spending time with family and doing the things they enjoy."

Mr Kerruish also said recipients of medical cannabis would benefit from "clinical expertise and robust ongoing care" to ensure it is effective in "managing their symptoms and improving their quality of life".

Dr David Gwynne, medical director at Boots Online Doctor, stressed that the drug is "not appropriate for everyone" and the need for decisions to be made "carefully on an individual patient basis".

"Sureleaf has therefore been designed with strong clinical safeguards and specialist oversight at every stage, so treatment is only considered for patients where it is clinically appropriate," he said. "Our priority is to ensure patients receive responsible, clinically-led care from their initial specialist assessment through to ongoing monitoring and review once treatment begins."

It comes after Boots was acquired by Canadian firm Whittington Investments in early October.

Opening of the article, excerpted from Daily Express. To read the rest, open the article on the publisher's site.

Read the full article on Daily Express Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.express.co.uk)

Also worth reading